Reuters logo
in 7 months
BRIEF-Ionis Pharmaceuticals reports positive data from phase 2 study of ionis-gcgr rx in patients with type 2 diabetes
January 4, 2017 / 12:16 PM / in 7 months

BRIEF-Ionis Pharmaceuticals reports positive data from phase 2 study of ionis-gcgr rx in patients with type 2 diabetes

1 Min Read

Jan 4 (Reuters) - Ionis Pharmaceuticals Inc :

* Ionis Pharmaceuticals reports positive data from phase 2 study of ionis-gcgr rx in patients with type 2 diabetes

* Ionis Pharmaceuticals - company to present top-line results at pipeline update webcast on January 5

* Ionis Pharmaceuticals-statistically significant improvements in hemoglobin a1c (hba1c), other measures of glucose control after 26 weeks of treatment Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below